Conclusion In conclusion, this study identified an increasing trend in resistance to sulfisoxazole, tetracycline, and chloramphenicol among STEC O157 clinical isolates from human cases across the United States between 2010 and 2021.
← all excerpts
Assessing antimicrobial resistance in Shiga toxin-producing <i>Escherichia coli</i> O157 isolates from human clinical cases in the United States, 2010-2021.
1
—
—